Supplementary Protection Certificate Search
Details
- SPC number
- SPC/GB12/034
- Filing date
- 2 August 2012
Applicant(s) details
- Name
-
Chugai Seiyaku Kabushiki Kaisha
- Address
-
5 - 1 Ukima 5-chome
Kita-ku
Tokyo 115
Japan
- Name
-
Tadamitsu Kishimoto
- Address
-
3-5-31
Nakano-cho
Tondabayashi-shi
Osaka 584
Japan
Agent details
- Name
-
D Young & Co LLP
- Address
-
120 Holborn
LONDON
EC1N 2DY
Patent details
- Patent number
- EP0783893
- Title
-
Inhibition of abnormal growth of synovial cells using IL- 6 antagonist as active ingredient
UK authorisation details
- Authority date
- 16 January 2009
- UK authorisations
- EU/1/08/492/001-006
- EU/1/08/492/002
- EU/1/08/492/003
- EU/1/08/492/004
- EU/1/08/492/005
- EU/1/08/492/006
Product details
- Product description
-
Tocilizumab
- Status
- Granted
- 1 December 2014
- Product type
- Medicinal
Life details
- In force date
- 7 June 2015
- Actual expiry date
- 6 June 2020
- Maximum expiry date
- 6 June 2020
- Invalid date
- Lapsed date
- Lapsed status
-
Extension details
- Lodged date
- 11 May 2018
- Granted date
- 10 December 2018
- Refused date
- Revoked date
- 11 June 2020
- Expiry date
- 6 December 2020
- Authorisation number
- EU/1/08/492/001 EU/1
- Authorisation date
- 16 January 2009
Information concerning revocation actions and other legal proceedings on an SPC is included in the Patents Status Information record of the relevant patent.